Research Daily Summary
Research Daily Summary: What Happened on November 16, 2026
Veterans with Agent Orange exposure had higher risks of Parkinson’s and related disorders
Other studies tested a blood-protein diabetes model, CRISPR methods, gene delivery and engineered gut bacteria in cells and mice.
Today in brief
Among 4.47 million Vietnam-era veterans, reported Agent Orange exposure was associated with higher risks of Parkinson’s disease, REM sleep behavior disorder and dementia with Lewy bodies.1 A separate analysis found a larger increase in Parkinson’s risk among veterans with records of direct or occupational exposure.1
A 13-protein score predicted type 2 diabetes in UK Biobank participants better than a standard lipid ratio, but isn’t ready for clinical use.2 Researchers tested CRISPR methods for detecting unintended edits and activating genes in cell models, alongside a gene-delivery system and engineered bacteria that affected tumors and metabolism in mice.3456
Agent Orange exposure was associated with higher risks of three neurologic disorders
Among Vietnam-era veterans, self-reported Agent Orange exposure was associated with a 44% higher risk of Parkinson’s disease, a 78% higher risk of REM sleep behavior disorder and a 66% higher risk of dementia with Lewy bodies.1 Researchers analyzed Veterans Affairs records for 4.47 million veterans, followed for an average of 12.5 years from 1999 to 2022.1
Parkinson’s risk rose more in a separate group of 7,600 veterans whose records showed direct handling, spraying or service in spraying units.1 Over 15 years, estimated excess Parkinson’s cases were 4.6 per 1,000 people with registry-reported exposure and 15.4 per 1,000 with direct or occupational exposure, compared with veterans without documented exposure.1
The findings show an association, not that Agent Orange exposure caused these disorders.1
A protein score predicted diabetes better than a standard lipid ratio
Researchers combined measurements of 13 blood proteins with three routine clinical measures to estimate insulin sensitivity and predict chronic disease risk.2 Among about 20,000 UK Biobank participants, the model outperformed the triglyceride-to-HDL cholesterol ratio for predicting type 2 diabetes and performed about as well as HbA1c.2
The score was also associated with predictions of fatty liver, cardiovascular and chronic kidney diseases.2 In an independent cohort of about 1,700 people, a glucose-tolerance measure predicted diabetes better than the model.2 Larger, more diverse studies and prospective validation are needed before clinical use.2
Superb-seq mapped unintended CRISPR edits and their effects in single cells
Salk Institute scientists and collaborators described Superb-seq, a method that detects CRISPR edits and measures their effects on gene expression in individual cells.3 The team tested the method in 34,000 cells across three cell lines.3
In a group of 10,000 human leukemia cells targeted with seven guide RNAs, Superb-seq detected 43 edit sites, 36 unintended, across 5,761 edited cells.3 The researchers said Superb-seq detects gene-expression effects that existing approaches miss and could help assess genome-therapy candidates during development.3
AAV.APR31 delivered genes to T and NK cells at lower doses than AAV6
Researchers developed AAV.APR31, a viral capsid that transduced primary human T and natural killer (NK) cells at doses nearly 100 to 1,000 times lower than AAV6 required.5 The variant supported temporary gene delivery and stable engineering, including targeted genomic insertion.5
CAR-T cells made with AAV.APR31 functioned comparably to cells made with lentiviral vectors.5 After systemic administration, the engineered cells controlled tumors in mouse models of blood cancers and solid tumors.5
CRISPR activation shifted autism cell models toward typical gene expression
UCLA-led researchers used enhancer-targeted CRISPR activation to increase CHD8 and SCN2A expression in mutant neurons and cortical organoids.4 The intervention shifted gene-expression patterns toward wild-type levels, reduced organoid size in most CHD8-mutant lines and moved electrical firing in SCN2A-mutant neurons closer to wild-type levels.4
The effects diminished over time, and the study authors said delivery and timing need more work before clinical use is possible.4
Engineered gut bacteria improved metabolic measures in aged mice
Centenarians had higher levels of certain microbe-modified bile acids than younger groups, but the human data don’t establish that microbial changes cause exceptional longevity.6 Researchers gave aged mice engineered gut bacteria that continuously produce bile salt hydrolase, an enzyme that modifies bile acids.6
About 20 weeks after treatment, the mice had better insulin sensitivity and modestly better glucose tolerance than controls.6 At 32 weeks, treated mice also showed changes consistent with lower weight and fat mass and higher lean mass.6
Also worth knowing
-
N
A bubble-powered microswarm isolated extracellular vesicles in 10 minutes at nearly 90% efficiency and detected non-small cell lung cancer in a pilot cohort with up to 94% accuracy and 95% sensitivity.7
-
P
In mice with a catalytically inactive Shp2 mutation, the allosteric inhibitor SHP099 alleviated hydrocephalus, while PI3K inhibition improved cilia-development defects.8
Also published
- GLP-1s and the limits of postnormal science C&EN Pharmaceuticals
- Editorial: GLP-1s and the limits of postnormal science C&EN Pharmaceuticals
- Affinity measurements in a single NMR tube, with a little help from fluorine Practical Fragments
- Addendum: A meta-analysis of GFR slope as a surrogate endpoint for kidney failure Nature Medicine